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Introduction {#sec1}
============

How organelles communicate is a fundamental question that arises given the compartmentalized nature of eukaryotic cell function. Although vesicular traffic is an established means of information transfer, it is becoming clear that traffic also proceeds by non-vesicular means. In particular, membrane contact sites have emerged as potential platforms for both Ca^2+^ signaling and lipid transfer ([@bib17], [@bib32], [@bib23], [@bib9]). Membrane contact sites are regions of close apposition between membranes that are stabilized by tethering complexes. The endoplasmic reticulum (ER) forms multiple classes of contacts with both the plasma membrane and organelles such as endosomes, lysosomes, and mitochondria. Endosome-ER contacts have been implicated in endosome positioning ([@bib37], [@bib35]), dephosphorylation of internalized receptors, and components of the endosomal sorting complex required for transport (ESCRT) machinery ([@bib10], [@bib11], [@bib43]), endosome fission ([@bib38]), actin nucleation and retromer-dependent budding ([@bib8]), and cholesterol transport ([@bib11]). We have identified multiple populations of contact sites that form between the ER and different endocytic organelles ([@bib11]), which include those dependent on VAPs ([@bib8]). Notably, contact sites between the ER and EGF receptor-containing endosomes require annexin-A1 and its Ca^2+^-dependent binding partner S100A11 ([@bib11]), raising the possibility that Ca^2+^ fluxes may regulate contact.

Ca^2+^ is a widespread signaling ion regulating a range of cellular processes including aspects of vesicle formation, fusion, and traffic ([@bib2]). Ca^2+^ signals often invade the cell entirety (global) but they can also be spatially restricted (local), as exemplified by signals generated by the Ca^2+^-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate (NAADP) ([@bib14]). NAADP is unusual in mediating Ca^2+^ release from the endo-lysosomal system, an acidic Ca^2+^ store filled by Ca^2+^/H^+^ exchange ([@bib6], [@bib31], [@bib27]). It does so by activating two-pore channels (TPCs) ([@bib5], [@bib3], [@bib30]). Local NAADP-mediated Ca^2+^ release events from acidic organelles are amplified by Ca^2+^ channels on canonical Ca^2+^ stores of the ER to generate global signals ([@bib14]). This occurs during signaling by external cues such as hormones and neurotransmitters ([@bib44], [@bib29]). However, it is also evident that local TPC-mediated Ca^2+^ release events function in a constitutive manner. For instance, NAADP/TPC signaling regulates several membrane trafficking events, including retrograde traffic from endosomes to the Golgi ([@bib39], [@bib40]) and the trafficking of cholesterol, receptors, and viruses ([@bib16], [@bib40], [@bib41]). This pathway also regulates endo-lysosomal morphology ([@bib24], [@bib18], [@bib30]), likely through Ca^2+^-dependent vesicular fusion/fission events ([@bib33], [@bib25], [@bib26]). However, what role TPCs play in non-vesicular trafficking is unexplored ([@bib4]).

Here, we reveal an essential requirement for NAADP and TPC1 in regulating membrane contact site formation between endosomes and the ER to control growth factor signaling.

Results {#sec2}
=======

NAADP and TPC1 Maintain Late Endosome and Lysosome Morphology {#sec2.1}
-------------------------------------------------------------

We examined the effect of inhibiting NAADP action on late endosome and lysosome morphology in primary human fibroblasts using four approaches.

First, we tested NAADP antagonists. [Figures 1](#fig1){ref-type="fig"}A and 1B show the effect of an overnight treatment with Ned-19 ([@bib28]) on late endosome and lysosome morphology as assessed by immuno-fluorescence staining and confocal microscopy of the late endosome and lysosome marker LAMP1. Labeled structures were clustered in the perinuclear region and often appeared enlarged ([Figure 1](#fig1){ref-type="fig"}B; changes in staining intensity quantified in [Figure 1](#fig1){ref-type="fig"}H). Similar results were obtained with the recently described Ned-19 analog, Ned-K ([@bib18], [@bib7]) ([Figure 1](#fig1){ref-type="fig"}C) and upon shorter (2-hr) treatment with the antagonists ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C and S1I). Analysis of multiple individual labeled structures revealed an increase in the mean area ([Table S1](#mmc1){ref-type="supplementary-material"}). LAMP1 protein levels were similar upon Ned-19 treatment ([Figure S1](#mmc1){ref-type="supplementary-material"}J). We further examined the ultrastructure of the endo-lysosomal system by electron microscopy (EM). Consistent with results using light microscopy, late endosomes and electron-dense lysosomes were often clustered and more vacuolar in Ned-19-treated cells compared with controls ([Figure 1](#fig1){ref-type="fig"}D; quantified in [Figure 1](#fig1){ref-type="fig"}I). Immuno-EM confirmed that LAMP1 localizes to late endosome and lysosome clusters in Ned-19-treated cells ([Figure S1](#mmc1){ref-type="supplementary-material"}K).

Second, we pharmacologically targeted the TPC pore. Recent studies have shown that TPCs are inhibited by the plant alkaloid tetrandrine ([@bib41]). Like NAADP antagonists, tetrandrine clustered late endosome and lysosomes and induced particularly pronounced vesicle enlargement ([Figures 1](#fig1){ref-type="fig"}E, 1J, [S1](#mmc1){ref-type="supplementary-material"}D, and S1I; [Table S1](#mmc1){ref-type="supplementary-material"}). TPCs have also emerged as targets for L-type Ca^2+^ channel blockers ([@bib34]). Therefore, we examined the effect of isradipine and nifedipine (both dihydropyridines), diltiazem (a benzothiazapine), and verapamil (a phenylalkylamine). As shown in [Figures S1](#mmc1){ref-type="supplementary-material"}E--S1I and [Table S1](#mmc1){ref-type="supplementary-material"}, all three structurally distinct classes of inhibitors induced aggregation/vesicle enlargement following an acute treatment.

Third, we buffered Ca^2+^ levels. Treatment of cells with the cell-permeable form of the Ca^2+^ chelator, 1,2-bis(*o*-aminophenoxy)ethane-*N*,*N*,*N′*,*N′*-tetraacetic acid (BAPTA), also altered the appearance of late endosome and lysosomes ([Figure 1](#fig1){ref-type="fig"}F). In contrast, treatment with the slower Ca^2+^ chelator EGTA did not ([Figure 1](#fig1){ref-type="fig"}G). This differential sensitivity to chelators ([@bib42]) summarized in [Figure 1](#fig1){ref-type="fig"}J suggests that morphology of the endo-lysosomal system is regulated by local Ca^2+^ fluxes.

Fourth, to directly probe the role of TPCs in endo-lysosomal morphology, we examined the effect of TPC knockdown. Treatment of fibroblasts with small interfering RNAs (siRNAs) targeting two independent sequences in both TPC1 or TPC2 reduced transcript levels \>50% ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Knockdown of TPC1 protein was confirmed by western blotting ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). As shown in [Figures 2](#fig2){ref-type="fig"}A--2C, confocal microscopy of TPC1-silenced cells revealed marked changes in LAMP1 staining (quantified in [Figure 2](#fig2){ref-type="fig"}F and [Table S1](#mmc1){ref-type="supplementary-material"}), similar to chemical blockade of NAADP signaling ([Figure 1](#fig1){ref-type="fig"}). TPC2 silencing, however, had little effect ([Figures 2](#fig2){ref-type="fig"}D and 2E). In accord, late endosome and lysosomes appeared more clustered and less distinct upon TPC1, but not TPC2, silencing at the ultrastructural level ([Figures 2](#fig2){ref-type="fig"}G--2K, quantified in [Figure 2](#fig2){ref-type="fig"}L). To assess specificity of our molecular manipulations, we performed rescue experiments with a siRNA-resistant TPC1 construct. Expression of this construct in TPC1-depleted cells partially reversed clustering of late endosome and lysosomes as assessed by both LAMP1 immunocytochemistry ([Figures 3](#fig3){ref-type="fig"}A and 3B) and correlative light and electron microscopy (CLEM) ([Figures 3](#fig3){ref-type="fig"}C and 3D), thereby attesting to specificity. Late endosome and lysosomal morphology was also unchanged by Ned-19 in cells where both TPC1 and TPC2 had been silenced ([Figures S2](#mmc1){ref-type="supplementary-material"}D--S2F), further attesting to specificity. Late endosome and lysosomal form is thus specifically determined by TPCs in an isoform-selective manner.

Taken together, we identify an unexpected role for NAADP, a target channel, and associated local Ca^2+^ fluxes in maintaining late endosome and lysosomal morphology.

TPC1 Localizes to Endosome-ER Contact Sites and Regulates Their Formation {#sec2.2}
-------------------------------------------------------------------------

The distribution of TPC1 within the endocytic pathway is unclear and likely more diffuse than that of TPC2, which is expressed predominantly on lysosomes ([@bib3]). Immuno-EM revealed localization of GFP-tagged or untagged TPC1 to the limiting membrane of multi-vesicular endosomes, rather than electron-dense lysosomes, with some additional ER localization that might be related to ectopic expression ([Figures 4](#fig4){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}A--S3C). Parallel studies with TPC2, however, were ambiguous because expression of TPC2 resulted in a proliferation of endocytic organelles with disorganized membranous content, often aggregated in clusters ([Figure 4](#fig4){ref-type="fig"}A). TPC2-mediated disruption of late endosome-lysosomal morphology is consistent with our previous analysis ([@bib24]). Intriguingly, we found that TPC1 was often found at membrane contact sites between endosomes and the ER ([Figures 4](#fig4){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}A--S3C). Quantitative analysis of TPC1-positive endosomes showed that there was a ∼5-fold increase in the number of gold particles/unit endosomal membrane in contact with the ER compared to regions not associated with the ER ([Figure 4](#fig4){ref-type="fig"}B). TPC1 thus emerges as a component of ER-endosome contacts.

The presence of TPC1 at ER-endosome contact sites raised the possibility that local Ca^2+^ signals deriving from the endosome may regulate contact with the ER. We therefore examined the effect of NAADP blockade on ER-endosome contact site formation ([Figure 4](#fig4){ref-type="fig"}C). As shown in [Figure 4](#fig4){ref-type="fig"}D, Ned-19 reduced the percentage of endosomes with an ER contact. Similar results were obtained in HeLa cells where Ned-19 reduced ER-endosome contact site formation in a concentration-dependent manner ([Figure S3](#mmc1){ref-type="supplementary-material"}D). The effects of Ned-19 were recapitulated by knocking down TPC1, whereas depletion of TPC2 had little effect on ER-endosome contacts in fibroblasts ([Figure 4](#fig4){ref-type="fig"}D). Chemical and molecular inhibition of NAADP signaling on contact site formation thus mirrors the effect on gross late endosome and lysosomal morphology ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}).

The ER forms contacts with lysosomes ([@bib21]) that are biochemically distinct from those with endosomes ([@bib11]). To assess specificity of our manipulations, we examined the effect of NAADP blockade on ER-lysosome contact site formation ([Figure 4](#fig4){ref-type="fig"}C). Ned-19 had little effect on the percentage of lysosomes with an ER contact in both fibroblasts ([Figure 4](#fig4){ref-type="fig"}E) and HeLa cells ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Silencing of TPC1 was also largely without effect, whereas silencing of TPC2 reduced ER-lysosome contact sites ([Figure 4](#fig4){ref-type="fig"}E).

In summary, these data uncover a highly isoform- and compartment-specific role for NAADP signaling in the formation of membrane contacts between endosomes and the ER.

NAADP Regulates EGF Signaling {#sec2.3}
-----------------------------

We have shown previously that ER-endosome contacts enable the interaction between endocytosed EGF receptor (EGFR) tyrosine kinase and the protein tyrosine phosphatase, PTP1B, on the ER ([@bib10]). This contact allows receptor de-phosphorylation---a determinant of signaling by EGF. We reasoned that disrupting NAADP signaling would enhance EGF signaling due to compromised contact at the ER-endosome interface. To test this, we examined the effect of Ned-19 on the phosphorylation state of EGFR. Acute stimulation with EGF induced a transient rise in EGFR tyrosine phosphorylation that was significantly enhanced and prolonged by Ned-19 treatment ([Figure 5](#fig5){ref-type="fig"}A, quantified in [Figures 5](#fig5){ref-type="fig"}B, [S4](#mmc1){ref-type="supplementary-material"}A, and S4B). For these experiments, we used HeLa cells due to their high EGFR levels, but similar results were obtained in fibroblasts ([Figures S4](#mmc1){ref-type="supplementary-material"}B--S4D).

To examine downstream functional consequences of disrupting contacts, we took two approaches.

First, we measured ERK activity because activated EGFRs are classically coupled to the MAP kinase pathway. Consistent with the prolonged EGFR activation observed in cells treated with Ned-19, tyrosine phosphorylation of ERK1/2 was significantly increased and extended upon NAADP inhibition ([Figures 5](#fig5){ref-type="fig"}C and 5D).

Second, we measured cytosolic Ca^2+^ levels. Activated EGFRs also couple to phospholipase C-gamma (PLCγ), which generates inositol 1,4,5-trisphosphate, resulting in Ca^2+^ release from ER Ca^2+^ stores. EGF evoked readily measurable Ca^2+^ signals that were exaggerated and more sustained in cells treated with Ned-19 for 2 hr or overnight ([Figures 5](#fig5){ref-type="fig"}E--5H). Total levels of the EGFR were unchanged ([Figures S4](#mmc1){ref-type="supplementary-material"}E--S4G), indicating that enhanced signaling effects are not attributable to increased expression of EGFR. These data are again consistent with prolonged activation of EGFR due to perturbed contact at NAADP-sensitive endosome-ER contact sites.

Taken together, these data reveal a role for NAADP in regulating both EGFR activity and downstream signaling by MAP kinase and phospholipase C.

Discussion {#sec3}
==========

Membrane contact sites between endosomes and the ER are gaining much attention as novel coordinators of cell function ([@bib36]). Contact with the ER is regulated by cholesterol ([@bib37]) and increases as endocytic vesicles mature ([@bib13]). Previous studies have shown marked upregulation of contacts in response to expression of STARD3/STARD3NL ([@bib1]), ORP1L ([@bib37]), and protrudin ([@bib35]), but whether these proteins are necessary for contact site formation is less clear. Here, we use EM, which, relative to light microscopy, is better suited for resolving inter-organelle junctions to provide direct evidence that TPC1 is a contact site component ([Figure 4](#fig4){ref-type="fig"}). Importantly, inhibiting TPC1 activity using chemical and molecular means significantly decreased ER contact site formation with late endosomes ([Figure 4](#fig4){ref-type="fig"}). This was associated with disruptions in late endosome and lysosome morphology ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}), although whether TPC1 and LAMP1 co-localize to junction-forming organelles remains to be established. Consistent with a role for ER-endosome contact sites in endosomal positioning ([@bib37], [@bib20]), we observed a more perinuclear population of LAMP1-positive late endosome and lysosomes when contact was reduced by inhibition of NAADP or TPC1 ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). We thus provide key evidence implicating endogenous NAADP signaling in regulating ER-endosome contact and the subcellular distribution of endocytic organelles.

Localized Ca^2+^ release from endocytic organelles is a driver of endosome-lysosome fusion ([@bib33]). In accord, TPCs associate with the fusion apparatus ([@bib24], [@bib16]) and have been implicated in a number of classical organellar vesicular trafficking events ([@bib26]). Our identification of ER-endosome contact sites dependent on annexin A1 ([@bib11]) and NAADP (this study) establishes a paradigm whereby localized Ca^2+^ release from endocytic organelles might regulate non-vesicular traffic. Of relevance are recent studies showing that Ca^2+^ regulates the formation of contacts between the ER and the plasma membrane ([@bib15]). Notably, the measured affinity for Ca^2+^ is in the low micromolar range, suggesting that large global signals, such as those evoked during Ca^2+^ influx, regulate these junctions ([@bib19]). However, because of the restricted volume at contacts, it is possible that even modest, constitutive fluxes in unstimulated cells, as alluded to here, could achieve the necessary Ca^2+^ concentrations to modulate Ca^2+^-dependent contacts. The effects of interfering with NAADP/TPC signaling on contact sites correlated well with effects on gross late endosome and lysosomal morphology. However, possible endosome-lysosome fusion defects might also contribute to morphological changes.

Activated EGF receptors undergo internalization onto endosomes where they continue to signal in their phosphorylated form until they are dephosphorylated by PTP1B on the ER. Disrupting ER-endosome contacts by inhibiting NAADP prolongs EGFR phosphorylation ([Figure 5](#fig5){ref-type="fig"}). These data support our findings that EGFR dephosphorylation occurs at endosome-ER contact sites populated by PTP1B and the Ca^2+^-binding protein annexin A1 ([@bib10], [@bib11]). Importantly, we also report that disruption of NAADP-dependent contacts substantially enhances downstream signaling by EGF through both ERK and PLCγ ([Figure 5](#fig5){ref-type="fig"}). Whether EGF receptors are coupled to NAADP production similar to vascular endothelial growth factor (VEGF) receptors ([@bib12]) is not known at present. Rather our data identify NAADP as a negative regulator of EGF action through local signaling at the endosome-ER interface ([Figure S4](#mmc1){ref-type="supplementary-material"}H). Many external stimuli elevate NAADP levels ([@bib14]), raising the possibility that second messenger and mitogenic signaling crosstalk may occur through modulation of contact site strength.

In summary, our findings provide new information on the molecular makeup, regulation, and function of ER-endosome contact sites.

Experimental Procedures {#sec4}
=======================

Cell Treatments {#sec4.1}
---------------

Primary cultured human fibroblasts and HeLa cells were maintained in DMEM supplemented with 10% (v/v) fetal bovine serum, 100 units/mL penicillin, and 100 μg/mL streptomycin (all from Invitrogen) at 37°C in a humidified atmosphere with 5% CO~2~. Cells were passaged by scraping (fibroblasts) or with trypsin (HeLa cells) and plated onto coverslips (for immunocytochemistry, Ca^2+^ imaging, and electron microscopy) or directly onto tissue culture plates/flasks (for western blotting) before experimentation.

For chemical treatments, drugs were dissolved in DMSO or H~2~O, diluted into culture medium, and then sterile filtered. The NAADP antagonists, *trans*-Ned-19 and Ned-K were synthesized as described by [@bib28] and [@bib7], respectively. Both were kind gifts from Raj Gossain, A. Ganesan, and Sean M. Davidson. BAPTA-AM was from Biovision. EGTA-AM was from AnaSpec. Tetrandrine was from Santa Cruz. Isradipine, nifedipine, verapamil, and diltiazem were from Sigma.

Knockdown was performed by transfecting cells with control siRNA duplex (Allstars Negative Control siRNA; QIAGEN) and duplexes targeting human TPC1 (\#1, AGCUGUAUUUCAUCAUGAAtt; \#2, GGCUACUAUUAUCUCAAUAtt) and TPC2 (\#1, GGUGGGACCUCUGCAUUGAtt; \#2, CGGUAUUACUCGAACGUAAUtt) (\#1, QIAGEN; \#2, Ambion) using Lipofectamine RNAiMAX as described previously ([@bib18]). For overexpression, cells were transfected with untagged TPC1 or C-terminally GFP-tagged human TPC1 and TPC2 as described by [@bib3], or a rescue construct in which the target sequence of siRNA\#1 in TPC1-GFP was mutated to [T]{.ul}GA[A]{.ul}CT[C]{.ul}TA[C]{.ul}TT[T]{.ul}AT[A]{.ul} using the Q5 site-directed mutagenesis kit (NEB) with forward (actttataATGAACCTGCTTCTGGCT) and reverse (agagttcaATGGAGAGGTACACGATG) primers.

Stimulation with EGF (100 ng/mL; Sigma) was performed following serum starvation for 1 hr in serum-free DMEM.

Immunocytochemistry {#sec4.2}
-------------------

LAMP1 labeling and confocal microscopy were performed as described by [@bib18]. Briefly, all images were acquired under identical confocal settings and mean fluorescence intensity per cell quantified to allow comparison between controls and the various treatments. Automated size analysis of labeled structures was performed using the "Analyze Particle" function in Fiji from binary images created by local thresholding using the Bernsen algorithm (5-pixel radius with the default contrast threshold) and Watershed segmentation.

Electron Microscopy {#sec4.3}
-------------------

EM was performed essentially as described ([@bib11]). Briefly, serum-starved cells were stimulated with EGF and BSA-gold. After fixation in paraformaldehyde (PFA)/glutaraldehyde, cells were post-fixed in osmium tetroxide/potassium ferricyanide and embedded. Clustering was quantified by calculating the area (using Fiji) of three or more late endosomes/lysosomes in close apposition relative to the cytoplasmic area (excluding the nucleus). For pre-embedding labeling, cells were fixed in PFA, permeabilized with digitonin, and incubated with primary and nanogold-secondary antibodies prior to fixation for EM. ER-endosome contact sites in random sections were defined as regions where apposing membranes were \<30 nm apart, with no minimum length. For correlative light and electron microscopy (CLEM), cells were plated on gridded dishes, fixed in 4% PFA, and imaged by light microscopy (Nikon Ti-E), prior to preparation for conventional EM as above.

Ca^2+^ Imaging {#sec4.4}
--------------

Cytosolic Ca^2+^ concentration was measured essentially as described ([@bib22]). In brief, cells were loaded with the fluorescent Ca^2+^ indicator Fura-2 in HEPES-buffered saline. Dual excitation time-lapse fluorescence imaging was performed using a CCD camera. Data are presented as fluorescence ratios upon excitation at 340 and 380 nm.

Other Methods {#sec4.5}
-------------

Quantitative PCR and western blotting were performed exactly as described by [@bib18]. The primary antibodies used for western blotting were anti-LAMP1 (mouse; Santa Cruz; 1/500; 1 hr room temperature \[RT\]), anti-TPC1 (rabbit; Abcam; 1/200; 1 hr RT), anti-actin (goat; Invitrogen; 1/500; 1 hr RT), anti-phosphotyrosine 1068 EGFR (rabbit; Cell Signaling; 1/2,000; 1 hr RT), anti-EGFR (sheep; Fitzgerald; 1/2000; 1 hr RT), anti-phosphotyrosine 204 ERK1/2 (mouse; Santa Cruz; 1/1,000), and anti-ERK1/2 (rabbit; Cell Signaling; 1/1,000).
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====================
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![NAADP Signaling Maintains Late Endosome and Lysosomal Morphology\
(A--C) Representative confocal images of LAMP1 staining (white) in fibroblasts treated overnight with either DMSO (0.1%) (A) or the NAADP antagonists, Ned-19 (100 μM) (B) and Ned-K (100 μM) (C). Nuclei were stained using DAPI (blue). Zoomed images are displayed in the right panels. Scale bars, 10 μm.\
(D) Representative electron micrographs of the endo-lysosomal system in fibroblasts treated overnight with either DMSO (0.1%) (left) or Ned-19 (100 μM) (right). Regions of interest corresponding to endo-lysosome clusters, the nucleus, and the cell entirety are highlighted. Scale bars, 5 μm.\
(E--G) LAMP1 staining in fibroblasts treated overnight with the TPC blocker, tetrandrine (Tet, 10 μM) (E) or for 2 hr with acetoxymethyl (AM) esters of the Ca^2+^ chelators BAPTA (50 μM) (F) or EGTA (50 μM) (G).\
(H--J) Summary data quantifying LAMP1 intensity in cells treated with NAADP antagonists (H) (95--299 cells from 3--11 independent treatments), clustering of endo-lysosomes in cells treated with Ned-19 expressed as a percentage of the area occupied relative to non-nuclear cytoplasm (I) (ten cells under each condition), and LAMP1 intensity in cells treated with tetrandrine/Ca^2+^ chelators (J) (73--116 cells from three to five independent treatments). Data are presented as a percentage of DMSO controls (±SEM).\
See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![TPC1 Maintains Late Endosome and Lysosomal Morphology\
(A--E) Representative LAMP1 staining (white) in fibroblasts transfected with scrambled (Scr) siRNA (A) or with two independent siRNAs targeting TPC1 (B and C) or TPC2 (D and E) for 48 hr. Nuclei were stained using DAPI (blue). Zoomed images are displayed in the right panels. Scale bars, 10 μm.\
(F) Summary data quantifying LAMP1 intensity as a percentage of scrambled control (± SEM). Data are from 57--496 cells from 3--11 independent knockdowns.\
(G--K) Representative electron micrographs of the endo-lysosomal system in fibroblasts transfected with Scr siRNA (G) or with siRNAs targeting TPC1 (H--I) or TPC2 (J--K). Scale bar, 500 nm.\
(L) Summary data quantifying clustering of endo-lysosomes expressed as a percentage of the area occupied relative to non-nuclear cytoplasm. Data are from ten cells under each condition and normalized relative to Scr siRNA (± SEM).\
See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![TPC1-Mediated Late Endosome and Lysosome Morphology Defects Are Rescuable\
(A) Representative LAMP1 staining (white) in fibroblasts transfected with TPC1 siRNA\#1 and GFP-tagged siRNA-resistant TPC1 (green). Nuclei were stained using DAPI (blue). Zoomed images of cells that were negative (gray box) and positive (green box) for GFP are displayed in the right panels. Scale bars, 10 μm.\
(B) Summary data quantifying LAMP1 intensity as a percentage of scrambled control (± SEM). Data are from 18--30 cells from two independent knockdowns.\
(C) Representative CLEM of cultures similar to (A) with light microscopy images shown in the top panel (scale bar, 50 μm) from which a pair of cells (black blox; scale bar, 20 μm) were identified for EM. Bottom panels show cropped EM images of the cells in their entirety (center; scale bars, 2 μm) and zoomed images of the indicated region from the cell that was GFP-negative (left) and GFP-positive (right; scale bars, 1 μm).\
(D) Summary data quantifying clustering of late endosomes/lysosomes expressed as a percentage of the area occupied relative to non-nuclear cytoplasm (± SEM). Data are from four cells under each condition.](gr3){#fig3}

![TPC1 Localizes to ER-Endosome Contact Sites and Regulates Their Formation\
(A and B) Electron micrographs showing distribution of TPC1 and TPC2 in fibroblasts (A) and localization of TPC1 at contact sites (B). Summary data quantifying the presence of TPC1 at contact versus non-contact sites are shown to the right. Cells were transfected with GFP-tagged TPC constructs and stained for GFP (white arrows) using pre-embedding labeling. Scale bar, 200 nm. Black arrows, ER contact sites.\
(C--E) Electron micrographs showing ER membrane contact sites between late endosomes and lysosomes in fibroblasts treated with a scrambled siRNA, 100 μM Ned-19, or with siRNA targeting TPC1 or TPC2 (C). The percentage of endosomes (D) or lysosomes (E) with an ER contact site were quantified. Data are from three independent treatments (± SEM). Scale bar, 200 nm. Black arrows, ER contact sites.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![NAADP Regulates EGF Signaling\
(A) Representative western blot using antibodies to phosphotyrosine (pY) 1068 EGFR (top) or total EGFR (bottom) and homogenates from HeLa cells. Cells were treated with either DMSO (0.1%) or Ned-19 (100 μM) overnight and serum starved for 1 hr prior to EGF (100 ng/mL) stimulation for the indicated times.\
(B) Summary data analyzing pY-EGFR levels (normalized to total EGFR) in lysates quantified as a percentage of DMSO control 10 min after EGF stimulation. Data are from three independent treatments (± SEM).\
(C and D) Similar to (A) and (B) except western blots were performed with antibodies to pY 204 ERK1/2 or total ERK1/2 (C). Data are from three independent treatments (± SEM; D).\
(E) Pseudo-colored images of the fluorescence ratio of HeLa cells loaded with the Ca^2+^ indicator, Fura-2, and stimulated with EGF (100 ng/mL) for the times indicated. Cells were treated with DMSO (0.1%) or Ned-19 (100 μM) overnight. Scale bar, 50 μm.\
(F--H) Summary data quantifying the time course (F), area under the curve (AUC) (G, normalized to DMSO) and maximal change (Δ\[Ca^2+^\]) (H, normalized to DMSO) of cytosolic Ca^2+^ levels after stimulation with EGF for the indicated time. Data are from two to four independent treatments (± SEM) analyzing 309--828 cells.\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

[^1]: Co-first author

[^2]: Lead Contact
